CDC and U.S. Public Health Service Release PrEP Guidelines

Federal Guidelines

On May 14, 2014, the US Public Health Service released the first comprehensive clinical practice guidelines for PrEP.  The guidelines were developed by a federal inter-agency working group led by CDC, and reflect input from providers, HIV patients, partners, and affected communities. The new guidelines:

  • Provide clear criteria for determining a person’s HIV risk and indications for PrEP use.
  • Require that patients receive HIV testing to confirm negative status before starting PrEP.
  • Underscore importance of counseling about adherence and HIV risk reduction, including encouraging condom use for additional protection.
  • Recommend regular monitoring of HIV infection status, side effects, adherence, and sexual or injection risk behaviors.
  • Include a providers’ supplement with additional materials and tools for use when prescribing PrEP.

The new federal guidelines recommend that PrEP be considered for people who are HIV-negative and at substantial risk for HIV.

 Click here to read the guidelines.